Training Diagnostic Specialists to Use Artificial Intelligence Safely: The DISCORD-Dx Study
DISCORD-Dx
DISCORD-Dx as a Cognitive Strategy for Calibrated Reliance on AI in Diagnosis
1 other identifier
interventional
46
1 country
1
Brief Summary
This randomized study evaluated whether a structured reasoning strategy called DISCORD-Dx could help specialist doctors use artificial intelligence (AI) recommendations more safely during diagnostic decision-making. The strategy was designed to help specialists benefit from correct AI advice while resisting plausible but incorrect AI recommendations. Forty-six consultant specialists in pathology and diagnostic radiology from two hospitals in Bahawalpur, Pakistan, were randomly assigned to receive either DISCORD-Dx training or time-matched conventional AI-literacy training. During assessment, participants first recorded and locked their own diagnosis before seeing a standardized AI recommendation. They then reviewed the AI advice and entered a final diagnosis. The AI recommendations included both correct recommendations and deliberately generated plausible errors that had been independently reviewed by specialists. The main outcome was appropriate reliance on AI, defined as following correct AI advice or resisting erroneous AI advice immediately after training. Other outcomes included harmful switching from a correct diagnosis to an incorrect diagnosis after erroneous AI advice, over-reliance, under-reliance, final diagnostic accuracy, decision time, and appropriate reliance at 8 weeks. No participant interacted with a live AI system, and study responses did not affect patient care.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Jun 2026
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 6, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 8, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
September 2, 2026
CompletedFirst Submitted
Initial submission to the registry
September 15, 2026
CompletedFirst Posted
Study publicly available on registry
September 28, 2026
CompletedSeptember 28, 2026
September 1, 2026
1 month
September 15, 2026
September 21, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Proportion of Case-Level Decisions Demonstrating Appropriate Reliance on AI Recommendations
Appropriate reliance was assessed at the case level and defined as following a correct AI recommendation or resisting an erroneous AI recommendation. Each participant completed eight unseen specialty-specific cases during the immediate assessment, including four cases with correct AI recommendations and four with erroneous AI recommendations. The outcome was expressed as the proportion of case-level decisions meeting the definition of appropriate reliance.
Immediately after training, during the 8-case post-training assessment
Secondary Outcomes (7)
Proportion of Eligible Erroneous-AI Case Decisions With Harmful Switching
Immediately after training, during the 8-case post-training assessment
Proportion of Erroneous-AI Case Decisions Demonstrating Over-Reliance
Immediately after training, during the 8-case post-training assessment
Proportion of Correct-AI Case Decisions Demonstrating Under-Reliance
Immediately after training, during the 8-case post-training assessment
Proportion of Eligible Correct-AI Case Decisions With Beneficial Correction
Immediately after training, during the 8-case post-training assessment
Final Diagnostic Accuracy
Immediately after training, during the 8-case post-training assessment
- +2 more secondary outcomes
Other Outcomes (2)
Mean Absolute Confidence Error
Immediately after training, during the 8-case post-training assessment
Treatment-by-Domain Interaction for Appropriate Reliance
Immediately after training, during the 8-case post-training assessment
Study Arms (2)
DISCORD-Dx Training
EXPERIMENTALParticipants received a 20-minute standardized orientation on AI capabilities and limitations, confident error, verification, privacy, bias, and professional oversight, followed by a 40-minute structured DISCORD-Dx training module. The module covered seven steps: Diagnose independently; Inspect AI advice; Substantiate evidence; Classify disagreement; Override, modify, or accept; Review outcome; and Demonstrate transfer.
Conventional AI-Literacy Training
ACTIVE COMPARATORParticipants received the same 20-minute standardized orientation on AI capabilities and limitations, confident error, verification, privacy, bias, and professional oversight, followed by 40 minutes of conventional AI-literacy reinforcement and matched case discussion without the DISCORD-Dx mnemonic, disagreement taxonomy, or explicit accept/modify/override sequence.
Interventions
A structured 40-minute cognitive training intervention delivered after a common 20-minute AI-safety orientation. The DISCORD-Dx module taught seven steps: Diagnose independently; Inspect AI advice; Substantiate evidence; Classify disagreement; Override, modify, or accept; Review outcome; and Demonstrate transfer. Guided practice cases were included, and delivery was standardized using locked scripts and fidelity checklists.
A 40-minute active-control training intervention delivered after the same 20-minute AI-safety orientation. It reinforced conventional principles of AI literacy through matched case discussion but did not include the DISCORD-Dx mnemonic, disagreement taxonomy, or the explicit accept/modify/override sequence. Contact time, facilitator exposure, presentation format, and practice exposure were matched to the intervention group.
Eligibility Criteria
You may qualify if:
- Practicing consultant specialist with current independent diagnostic responsibility.
- Specialty in chemical pathology, hematology, microbiology, histopathology, or diagnostic radiology.
You may not qualify if:
- Trainee status.
- Absence of independent reporting responsibility.
- Direct involvement in constructing or validating the participant's specialty case bank.
- Prior access to assessment cases or scoring keys.
- Inability to complete the digital assessment.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Sara Rezalead
Study Sites (1)
Quaid-e-Azam Medical College
Bahawalpur, Punjab Province, 63100, Pakistan
Study Officials
- PRINCIPAL INVESTIGATOR
Sara Reza
Quaid-e-Azam Medical College
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Masking Details
- Outcome assessors were blinded to treatment allocation. The primary analyst also remained masked to treatment codes through response scoring and primary-model diagnostic checks. Participants and facilitators were not blinded because the training content differed between groups.
- Purpose
- OTHER
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Associate Professor
Study Record Dates
First Submitted
September 15, 2026
First Posted
September 28, 2026
Study Start
June 6, 2026
Primary Completion
July 8, 2026
Study Completion
September 2, 2026
Last Updated
September 28, 2026
Record last verified: 2026-09
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP, ICF
- Time Frame
- Data and supporting information will be available beginning 3 months after publication of the primary study results and will remain available for 5 years.
- Access Criteria
- Deidentified IPD and supporting information will be available to approved researchers under a data-use agreement, subject to institutional approval. Access will be limited to data and materials that can be shared without compromising participant confidentiality or the security and future reuse of assessment materials.
Deidentified individual participant data underlying the published results will be shared, including participant-level data and eligible case-level data used in the primary, secondary, and exploratory analyses. Data will be shared without direct personal identifiers and will be accompanied by a data dictionary and relevant analysis documentation.